Investigating Burnout in Intensive Care in Middle Incoming Turkey

NCT ID: NCT03313609

Last Updated: 2017-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-10

Study Completion Date

2017-11-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Turkey is a developing country and its intensive care infrastructure is worse than developed countries. The staff is very busy at work. Intensive care has become a new science. We wanted to investigate burnout syndrome among physicians and other health care workers who are starting to work at a new intensive care medicine. Intensive care specialists in Turkey do not work in intensive care centers where they want. This may have a negative effect on physicians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Burnuot health practices are more common than the normal group. The data about Turkey are limited. In developing societies, there are often no protocols in intensive care. There are no teams again during intensive care. All work is done by physicians and other health workers. This may adversely affect health care workers. Intensive care science is new. The training first started in 2013. The newly graduated heavy-duty specialists can work where they do not want. The workload of the health workers working in the intensive care unit is high. We wanted to investigate burnout on healthcare workers in Turkey.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burnout Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Investigating Burnout in Intensive Care in Middle Incoming Turkey

single-group studies

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ilhan bahar

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

fellow, nursing, specialist and academics working intensive care medicine
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr. Ersin Arslan Education and Training Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

gulserenelay

Dr. Ersin Arslan Education and Training Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Ersin Arslan Education and Training Hospital

Gaziantep, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

gulseren elay, specialist

Role: CONTACT

Phone: 905392904430

Email: [email protected]

ilhan bahar, specialist

Role: CONTACT

Phone: 905073499347

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

gulseren elay

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

No sponsor

Identifier Type: -

Identifier Source: org_study_id